Befunolol
From Wikipedia, the free encyclopedia
 |
|
|
Befunolol
|
|
| Systematic (IUPAC) name | |
| 1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]- 1-benzofuran-2-yl]ethanone |
|
| Identifiers | |
| CAS number | |
| ATC code | S01 |
| PubChem | |
| Chemical data | |
| Formula | C16H21NO4 |
| Mol. mass | 291.342 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||
